multiple sclerosis

adeona2

Adeona Names New Managers, Eyes Name Change

Adeona Pharmaceuticals Inc. has swapped bosses as it continues testing new drugs for multiple sclerosis, fibromyalgia and Lou Gehrig’s disease. It’s also considering a new business focus and a name change.

WWJ Newsradio 950–02/06/2012

adeona2

Adeona Starts Phase II Trials Of New MS Drug

Adeona Pharmaceuticals Inc. (NYSE Amex: AEN) said Thursday that it had started a Phase II clinical trial of Trimesta (oral estriol) for the treatment of cognitive dysfunction in multiple sclerosis in women.

WWJ Newsradio 950–01/19/2012

lycera

Lycera Achieves First Milestone in Merck Research Collaboration

Lycera Corp., a biopharmaceutical company creating innovative approaches to developing novel oral medicines to treat autoimmune diseases, today announced that it has reached the first milestone under its research collaboration with Merck, triggering a milestone payment.

WWJ Newsradio 950–12/21/2011

adeona2

Adeona Loss Grows, But Drug Trials Continue

The pharma startup Adeona Pharmaceuticals Inc. (AMEX: AEN), a developer of innovative medicines for serious central nervous system diseases, reported its third quarter 2011 financial results Monday.

WWJ Newsradio 950–11/14/2011

adeona2

Adeona Completes Enrollment In Phase II Trial Of MS Drug

Adeona Pharmaceuticals Inc. said Monday that the 150th patient has been enrolled in the randomized, double-blind, placebo-controlled, multi-center clinical trial of its Trimesta oral estriol drug candidate for relapsing-remitting multiple sclerosis in women.

WWJ Newsradio 950–09/19/2011

Facebook Photo

WWJ’s John Bailey Prepares For Charity Bike Ride

If you’re out and about at the Island Lake Recreation Area Saturday, you might see a familiar face. WWJ’s John Bailey will be going for a long bike ride for charity.

WWJ Newsradio 950–09/16/2011

adeona2

Adeona Loss Grows, But Milestones Reached

Ann Arbor-based Adeona Pharmaceuticals Inc. (AMEX: AEN), a developer of medicines for serious central nervous system diseases, Monday reported its second quarter financial results for the period ended June 30, as well as updates since the beginning of the second quarter.

WWJ Newsradio 950–08/15/2011

The Van Andel Institute in Grand Rapids. Photo: Wikimedia Commons

New Use For Old Drug — Arthritis, Cancer And More, VARI Says

New research from the Grand Rapids-based Van Andel Research Institute demonstrates on the molecular level how the anti-malaria drug chloroquine represses inflammation, which may provide a blueprint for new strategies for treating auto-immune diseases from […]

WWJ Newsradio 950–07/18/2011

MS logo

Facebook Works For Friends Of MS Society

Hunreds of folks responded to a posting on Facebook which noted an upcoming event to support the local chapter of Multiple Sclerosis society.

WWJ Newsradio 950–04/29/2011

adeona

Adeona to Raise $3.5 Million In Stock Offering

Ann Arbor-based Adeona Pharmaceuticals Inc. said Thursday that it had an agreement for the sale of 1,688,782 shares of its common stock at $2.0725 per share to a new institutional investor in a registered direct offering for $3.5 million in gross proceeds

04/07/2011

more

previous

Follow

Get every new post delivered to your Inbox.

Join 2,066 other followers